Propel Bio Management »

Simplify Exchange Traded Fun shares owned by Propel Bio Management

Quarter-by-quarter ownership of Simplify Exchange Traded Fun (HIGH) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Simplify Exchange Traded Fun

Tip: Access up to 7 years of quarterly data

All positions including Simplify Exchange Traded Fun held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Simplify Exchange Traded Fun by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 120k 24.56

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Simplify Exchange Traded Fun

Wells Fargo & Company
Private Advisor
Richard P Slaughter Associates
Astor Investment Management
Advisor Group Holdings
Peak Financial Advisors
AE Wealth Management
Flagship Harbor Advisors
Jane Street
Orion Portfolio Solutions
Branch Banking & Trust Company
3EDGE Asset Management
Simplify Asset Management
Propel Bio Management
BlackDiamond Wealth Management

View all funds holding Simplify Exchange Traded Fun